Med Ed 101
JANUARY 22, 2025
Do you ever get those questions where you know you are correct but you have to check the literature? I believe I’ve come across this order once or twice in my career: oral lorazepam PRN for a seizure. Can this be done? Here are the details on why this shouldn’t be done. Can I give […] The post Oral Lorazepam PRN For A Seizure? Is This Right?
The Checkup by Singlecare
JANUARY 22, 2025
Propranolol is widely prescribed to treat heart conditions such as high blood pressure, arrhythmias, angina (chest pain), or a combination of these conditions. It belongs to a class of drugs known as beta-adrenergic receptor antagonists, more commonly called beta blockers. Understanding this medications duration of action can help you better manage symptoms and avoid potential side effects from missed doses.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 22, 2025
The US government is entrusting mRNA vaccine pioneers Moderna to develop protection for the gradually increasing threat of avian influenza.
Pharmacy Times
JANUARY 22, 2025
The FDA approved treosulfan, in combination with fludarabine, for patients 1 year of age and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JANUARY 22, 2025
Erin Fox, PharmD, MHA, BCPS, FASHP, discussed the 2025 Pharmacy Forecast and its perspective on managing ultra-high-cost drugs.
PharmaVoice
JANUARY 22, 2025
The company is kicking off the year with a new Novartis partnership and renewed focus on metabolic aging targets.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JANUARY 22, 2025
An infusion and specialty clinical pharmacist is a valuable integrated member of the health care team as demonstrated by cost avoidance and high satisfaction reported by both veterans and specialty providers.
Fierce Healthcare
JANUARY 22, 2025
The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage star ratings. | The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage star ratings.
Pharmacy Times
JANUARY 22, 2025
Vusolimogene oderparepvec in combination with nivolumab is being assessed to treat individuals with unresectable or metastatic stage IIIb-IV cutaneous melanoma.
pharmaphorum
JANUARY 22, 2025
The UK government has launched a 150 million procurement drive for artificial intelligence tools that can be used by the NHS.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PhRMA
JANUARY 22, 2025
Making the best decision about which medicines to take should be a decision between patients and their doctors, not unelected bureaucrats. Price-setting boards, such as the prescription drug affordability board (PDAB) being proposed in Virginia, ignore this principle and threaten access to life-saving medicines.
pharmaphorum
JANUARY 22, 2025
A UK alliance between data scientists, clinical researchers, and community opticians hopes to develop an AI to predict dementia during an eye test.
The Happy PharmD
JANUARY 22, 2025
More and more pharmacists are walking away from the profession. The white coat is coming off, and pharmacists are heading for the exit. Its a mass exodus that’s just beginning, and its happening for a lot of reasons, each one contributing to a situation thats not just bad for the pharmacy industry but for healthcare as a whole If youre in pharmacy or know someone who is, youve probably noticed the increasing stress and dissatisfaction in the profession.
Fierce Healthcare
JANUARY 22, 2025
Primary care and women's health company Tia has big plans for 2025 as it aims to open more locations and partner with new health systems. | Primary care and women's health company Tia has big plans for 2025 as it aims to open more locations and partner with new health systems.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
JANUARY 22, 2025
Pharmacists ensure responsible antibiotic use, combating resistance through tailored therapies.
pharmaphorum
JANUARY 22, 2025
Johnson & Johnson's Spravato has become the first standalone drug to be cleared by the FDA for adults with treatment-resistant depression
Pharmacy Times
JANUARY 22, 2025
A panel of experts discuss treatment of HR+, HER2 breast cancer with therapies such as ribociclib, alpelisib, everolimus, and elacestrant.
Fierce Healthcare
JANUARY 22, 2025
Moodys, S&P and Fitch collectively issued 95 credit downgrades and 37 upgrades to nonprofit hospitals in 2024, a trend likely to continue in 2025, according to Kaufman Hall.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JANUARY 22, 2025
Engaging with the community, providing transparent information to patients, and using noncoercive methods of encouragement are strategies to reduce COVID-19 vaccine hesitancy.
Fierce Healthcare
JANUARY 22, 2025
Jay Chaudary, former director of the Indiana Division of Mental Health and Addiction, led the effort to overhaul the state's behavioral health system. He takes listeners through lessons learned and potential future policy threats to care access.
Pharmacy Times
JANUARY 22, 2025
Many treatments are off-label, so pharmacists can educate clinicians and help patients with access.
Pharma Times
JANUARY 22, 2025
Europes first biomarker trial seeks to prevent Crohns Disease onset
Pharmacy Times
JANUARY 22, 2025
Panelists discuss how the safety profiles of second-line primary biliary cholangitis (PBC) therapies in compensated cirrhosis show varying levels of risk, with recent abstracts from EASL and AASLD 2024.
pharmaphorum
JANUARY 22, 2025
Discover the key trends and innovations shaping the pharma and life sciences industries in 2025, focusing on efficiency, patient care, customer experience, and advancements in rare disease treatments.
Pharmacy Times
JANUARY 22, 2025
Panelists discuss how long-term safety monitoring for second-line primary biliary cholangitis (PBC) therapies requires systematic assessment of liver function, lipid profiles, and potential drug-specific adverse effects while emerging 5-year safety data for seladelpar continues to demonstrate a favorable risk profile compared with other treatment options.
Pharmaceutical Commerce
JANUARY 22, 2025
In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Donald Prentiss, founder and CEO, Qualthera, describes the importance of the patient within the pharma supply chain.
Pharmacy Times
JANUARY 22, 2025
Pharmacists play a significant role in managing gout by educating patients about the disease and ensuring proper medication adherence to urate-lowering therapy.
Pharmaceutical Technology
JANUARY 22, 2025
The FDAs decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.
Pharmacy Times
JANUARY 22, 2025
A phase 2 trial investigates MRD detection and therapy advancements.
Pharmaceutical Technology
JANUARY 22, 2025
Glox Therapeutics is set to receive a share of the 3m ($3.67m) Collaborative Discovery Programme (CDP) funding.
Pharmaceutical Commerce
JANUARY 22, 2025
The latest news for pharma industry insiders.
Pharmaceutical Technology
JANUARY 22, 2025
Tagrisso and Imfinzi are projected to generate global sales of $8bn and $7bn, respectively, by 2030, according to GlobalData.
Pharma Times
JANUARY 22, 2025
NICE endorses Imfinzi and Tagrisso for enhanced lung cancer care
Expert insights. Personalized for you.
Let's personalize your content